ctrl K

Price Alert

Mereo BioPharma Group (MREO)

NASDAQ: MREO · Real-Time Price · USD

1.68

-0.06 (-3.45%)

At close: Aug 18, 2025, 3:59 PM

1.68

0.00%

Pre-market: Aug 19, 2025, 08:02 AM EDT

Mereo BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	69.8M	57.42M	56.33M	94.3M
Short-Term Investments	n/a	n/a	51.1M	569K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-25.95M	-27.09M
Receivables	3.25M	3.73M	2.75M	1.42M
Inventory	n/a	n/a	-2.67M	-1.82M
Other Current Assets	507K	1.98M	1.43M	2.23M
Total Current Assets	74.76M	63.76M	62.13M	99.32M
Property-Plant & Equipment	984K	1.65M	1.83M	2.53M
Goodwill & Intangibles	643K	1.09M	24.12M	24.56M
Total Long-Term Assets	1.63M	2.74M	25.95M	27.09M
Total Assets	76.39M	66.5M	88.08M	126.42M
Account Payables	2.44M	2.35M	3.49M	2.29M
Deferred Revenue	n/a	n/a	n/a	8.37M
Short-Term Debt	5.54M	n/a	11.02M	n/a
Other Current Liabilities	2.87M	2.37M	5.82M	5.62M
Total Current Liabilities	13.85M	9.49M	24.68M	12.54M
Long-Term Debt	n/a	4.39M	n/a	n/a
Other Long-Term Liabilities	1.39M	1.18M	54K	36.04M
Total Long-Term Liabilities	1.57M	6.48M	1.53M	25.87M
Total Liabilities	15.42M	15.96M	26.21M	38.41M
Total Debt	6.43M	5.95M	12.77M	16.76M
Common Stock	3.06M	2.77M	1.88M	1.75M
Retained Earnings	-462.88M	-419.63M	-331.16M	-296.97M
Comprehensive Income	-18.85M	-17.48M	137.91M	136.9M
Shareholders Equity	60.97M	50.54M	61.87M	88M
Total Investments	n/a	n/a	51.1M	569K